Prospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Nov 16, 2021; 9(32): 9869-9877
Published online Nov 16, 2021. doi: 10.12998/wjcc.v9.i32.9869
Table 6 Comparison of serum levels of T-cell subsets between groups before and after the treatments (mean ± SD)
Group
n
Time
CD3+ (%)
CD4+ (%)
CD4+/CD8 (%)
CD8+ (%)
Experimental35Before treatment41.52 ± 5.2132.07 ± 3.310.51 ± 0.1552.25 ± 5.37
After treatment62.3 ± 5.53a,d43.4 ± 4.99a,d1.02 ± 0.29a,d40.52 ± 4.58a,d
Control33Before treatment 42.52 ± 4.5831.15 ± 3.250.55 ± 0.1352.12 ± 6.59
After treatment53.25 ± .6.62a37.72 ± 4.56a0.77 ± 0.15a48.46 ± 5.58a